The tetraspanin superfamily member NET-6 is a new tumor suppressor gene

被引:33
作者
Huang, Huayi
Sossey-Alaoui, Khalid
Beachy, Sarah H.
Geradts, Joseph
机构
[1] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA
[2] Roswell Pk Canc Inst, Dept Mol & Cellular Biophys & Biochem, Buffalo, NY 14263 USA
[3] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA
[4] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA
关键词
breast cancer; NET-6; tetraspanins; tumor suppressor gene;
D O I
10.1007/s00432-007-0221-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose NET-6 is a largely uncharacterized member of the tetraspanin superfamily. We have recently shown that its expression level was lowest in breast carcinomas with aggressive characteristics. We now describe the phenotypic and molecular changes induced in MDA-MB-231 breast carcinoma cells by ectopic NET-6 expression. Methods A GFP-NET-6 construct was transfected into very low expressing MDA-MB-231 cells. The subcellular distribution was studied by confocal microscopy. Cell proliferation in vitro was measured by MTT assay. Subcutaneous tumor formation in SCID mice was also studied. Other phenotypic parameters measured included growth in soft agar and extracellular matrix invasion. The effect of NET-6 transfection on the cell cycle was interrogated by flow cytometry. Deregulation of metalloproteinase expression was investigated by RT-PCR. Deregulation of proteins involved in apoptosis and cell cycle control was studied by Western blotting. Results Ectopic expression of NET-6 inhibited anchorage independent growth and invasion in a Boyden chamber assay. These effects were associated with downregulation of the matrix metalloproteinases MMP-1 and MMP-3. NET-6 had marked antiproliferative activity, both in vitro and in SCID mice. This effect was largely due to increased apoptosis. We identified upregulation of the pro-apoptotic molecules p53, bax, bak and caspase 3. Conclusions Our data provide novel and compelling evidence that NET-6 is a potent new breast cancer suppressor gene.
引用
收藏
页码:761 / 769
页数:9
相关论文
共 30 条
[1]   Characterization of integrin-tetraspanin adhesion complexes: Role of tetraspanins in integrin signaling [J].
Berditchevski, F ;
Odintsova, E .
JOURNAL OF CELL BIOLOGY, 1999, 146 (02) :477-492
[2]   Expression of the palmitoylation-deficient CD151 weakens the association of α3β1 integrin with the tetraspanin-enriched microdomains and affects integrin-dependent signaling [J].
Berditchevski, F ;
Odintsova, E ;
Sawada, S ;
Gilbert, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (40) :36991-37000
[3]   Tetraspanin CD81 is linked to ERK/MAPKinase signaling by Shc in liver tumor cells [J].
Carloni, V ;
Mazzocca, A ;
Ravichandran, KS .
ONCOGENE, 2004, 23 (08) :1566-1574
[4]   α3β1 integrin-CD151, a component of the cadherin-catenin complex, regulates PTPμ, expression and cell-cell adhesion [J].
Chattopadhyay, N ;
Wang, ZM ;
Ashman, LK ;
Brady-Kalnay, SM ;
Kreidberg, JA .
JOURNAL OF CELL BIOLOGY, 2003, 163 (06) :1351-1362
[5]   The tetraspanin CD81 is necessary for partitioning of coligated CD19/CD21-B cell antigen receptor complexes into signaling-active lipid rafts [J].
Cherukuri, A ;
Shoham, T ;
Sohn, HW ;
Levy, S ;
Brooks, S ;
Carter, R ;
Pierce, SK .
JOURNAL OF IMMUNOLOGY, 2004, 172 (01) :370-380
[6]   KAI1, A METASTASIS SUPPRESSOR GENE FOR PROSTATE-CANCER ON HUMAN-CHROMOSOME 11P11.2 [J].
DONG, JT ;
LAMB, PW ;
RINKERSCHAEFFER, CW ;
VUKANOVIC, J ;
ICHIKAWA, T ;
ISAACS, JT ;
BARRETT, JC .
SCIENCE, 1995, 268 (5212) :884-886
[7]   Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination:: Morphologic alteration and reduced expression of β1 integrin subsets [J].
Furuya, M ;
Kato, F ;
Nishimura, N ;
Ishiwata, I ;
Ikeda, H ;
Ito, R ;
Yoshiki, T ;
Ishikura, H .
CANCER RESEARCH, 2005, 65 (07) :2617-2625
[8]   Frequent loss of KAI1 expression in squamous and lymphoid neoplasms - An immunohistochemical study of archival tissues [J].
Geradts, J ;
Maynard, R ;
Birrer, MJ ;
Hendricks, D ;
Abbondanzo, SL ;
Fong, KM ;
Barrett, JC ;
Lombardi, DP .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (06) :1665-1671
[9]   Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients [J].
Huang, CI ;
Kohno, N ;
Ogawa, E ;
Adachi, M ;
Taki, T ;
Miyake, M .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (03) :973-983
[10]   MRP-1/CD9 gene transduction downregulates Wnt signal pathways [J].
Huang, CL ;
Liu, DG ;
Masuya, D ;
Kameyama, K ;
Nakashima, T ;
Yokomise, H ;
Ueno, M ;
Miyake, M .
ONCOGENE, 2004, 23 (45) :7475-7483